作者: P Zabel , P Entzian , K Dalhoff , M Schlaak
DOI: 10.1164/AJRCCM.155.5.9154873
关键词: Prednisone 、 Combination therapy 、 Internal medicine 、 Sarcoidosis 、 Surgery 、 Systemic disease 、 Tumor necrosis factor alpha 、 Pentoxifylline 、 Pharmacotherapy 、 Chemotherapy 、 Gastroenterology 、 Medicine
摘要: The optimal therapy for sarcoidosis remains unclear. Most patients show a short-term response to corticosteroid therapy, but they have to face the risk of significant side effects. Because …